https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
As of this writing, Kiniksa Pharmaceuticals International Plc (KNSA) has seen a significant price movement in recent days, with its stock price increasing by 16.93% over the past few hours. This surge is largely due to the company’s impressive Q1 earnings report, which beat analyst estimates. Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company that focuses … Read more
Today, almost all available birth control options are female contraceptives. Biotech company Contraline, however, claims that clinical trials for its non-hormonal and reversible male contraceptive have reached a critical milestone. In a news release published today, Contraline announced that its male contraceptive, named ADAM, proved to be effective and safe 24 months into its first … Read more
In a move that has sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) announced yesterday its plan to replace animal testing with “more effective, human-relevant methods,” including artificial intelligence (AI) models in drug development. And one stock is leading the charge: Recursion Pharmaceuticals Inc. (NASDAQ: RXRX). Shares of Recursion Pharmaceuticals … Read more
In a move that’s got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of strategic alternatives to maximize stockholder value. This news comes as of this writing, the company’s shares have surged 14.42% today, making it one of the biggest gainers in the market. As we take a closer look at this biotech … Read more
In today’s fast-paced market, it’s not uncommon for stocks to experience sudden surges in value. But when PacBio (NASDAQ:PACB) saw its stock price jump by 12.20% today, investors took notice. As we dive into this biotechnology company’s recent performance and prospects, one thing is clear: PacBio has a lot going on. The preliminary first-quarter revenue … Read more
and RYSE Hey 360 – here are some of our top movers today! 🧨 Special Invite Only Event, TODAY (NOW) starting at 9am. Watch to see if JW can call out another 50% SPY options runner and learn how he’s finding these gems. Please register here for access to the trading room! FOCUS LIST🔎 SCNI – Up … Read more
In a market where biotechnology stocks are often shrouded in uncertainty, TG Therapeutics (NASDAQ:TGTX) has emerged as one of the biggest winners today. The company’s stock price surged 17% after reporting fourth-quarter earnings that exceeded Wall Street expectations. But what’s behind this sudden surge? Let’s take a closer look at the numbers and see if … Read more
In a market where biotechnology stocks are often shrouded in uncertainty, Telix Pharmaceuticals (TLX) has emerged as one of the biggest gainers today. With its stock price surging by 20.51% to $23.50 per share, investors are taking notice. Telix is a clinical-stage oncology company that’s developing and commercializing therapeutic and diagnostic radiopharmaceuticals for various types … Read more
Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target so-called “circular RNA.” The development holds promise as a new method to quickly develop therapies for conditions that currently have no drug treatments. The new funding is also a victory lap for co-founder and CEO … Read more
As I scan the market, one stock that’s caught my attention is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). This clinical-stage biotechnology company has been making waves with its impressive gains in recent weeks, and today it’s up a whopping 23.88% – the largest gain of any stock on the NASDAQ. So, what’s behind this surge? Let’s take … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4